Skip to main
  1. Stocks
  2. Solventum Corporation
  3. Forecast
SOLV

Solventum Corporation (SOLV) Stock Forecast & Price Target

Solventum Corporation (SOLV) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 30%
Buy 40%
Hold 20%
Sell 0%
Strong Sell 10%

Bulls say

Solventum is well positioned because it has repeatedly beaten modest expectations, raised guidance for the third time this year, and delivered stronger margins, with 3Q revenue of $1,949M, adj. GM% of 57.1%, adj. OM% of 19.9%, and EPS of $1.45. Its outlook is further supported by the shift to a simpler portfolio after the purification and filtration sale and the planned HIS separation, while MedSurg—now about 64% of revenue—still has meaningful penetration opportunities in infection prevention and wound care. Management also reduced near-term cost risk by resolving the 3M supply agreement headwind, and it expects organic growth, margin expansion, and free cash flow to improve as separation-related costs roll off.

Bears say

Solventum is facing a challenging setup because downside to estimates could come from slower growth in its key segments, especially with medsurg now representing roughly 64% of revenue and the dental solutions and health information systems businesses each contributing about 18%. Margin expansion may also lag if operating improvements slow, while higher interest rates could keep interest expense elevated and pressure earnings quality. Competitive intensity in core categories, along with any negative updates on the separation of the HIS segment, adds further uncertainty to the company’s outlook.

Solventum Corporation (SOLV) has been analyzed by 10 analysts, with a consensus rating of Buy. 30% of analysts recommend a Strong Buy, 40% recommend Buy, 20% suggest Holding, 0% advise Selling, and 10% predict a Strong Sell.

This aggregate rating is based on analysts' research of Solventum Corporation and is not a guaranteed prediction by Public.com or investment advice.

Solventum Corporation (SOLV) Analyst Forecast & Price Prediction

Get the latest Solventum Corporation (SOLV) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Solventum Corporation (SOLV)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Solventum Corporation (SOLV) Forecast

Analysts have given Solventum Corporation (SOLV) a Buy based on their latest research and market trends.

According to 10 analysts, Solventum Corporation (SOLV) has a Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $94.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $94.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Solventum Corporation (SOLV)


Solventum Corporation (SOLV) Analyst Forecast & Price Prediction

Get the latest Solventum Corporation (SOLV) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Solventum Corporation (SOLV)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover SOLV stock data and trends